Company Overview

AXIM Biotechnologies (OTC: AXIM) is an international healthcare solutions company targeting ocular biomarkers. AXIM Eye is working with two highly specialized Point-of-Care (POC) lab testing solutions designed specifically to assist eye-care physicians in detecting and quantifying biomarkers associated with aqueous deficient dry eye disease and non-specific allergic conjunctivitis.

Investor Presentation

Email Alerts

Stay informed and receive company updates straight to your inbox

Recent News

Latest Annual Filing

Fiscal Year Ended Dec 31, 2021